Product Images Budesonide Inhalation
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Budesonide Inhalation NDC 0115-1689 by Amneal Pharmaceuticals Of New York Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a chart showing the mean change from baseline in nighttime asthma symptoms over a 12-week period. The chart includes data for a placebo group and two treatment groups, one taking 0.25 mg of medication twice daily and the other taking 0.5 mg twice daily. The chart presents data for specific time periods within the 12-week timeframe, including Week 0-2, Week 2-4, Week 4-6, Week 6-8, Week 8-10, and Week 10-12.*
This appears to be a section of a chart or graph related to a study on asthma symptoms at night over the course of 12 weeks. The chart shows different time periods and treatment groups (placebo, 0.25mg twice daily, and 0.5mg twice daily). The main focus seems to be on the weaning of a medication called "Uhange" in relation to baseline symptoms. However, without further context or information, the purpose and findings of the study cannot be fully determined.*
This is a prescription medicine called Budesonide Inhalation Suspension. The instructions on how to use this medication are included. It comes in a box that contains 30 small vials (ampules) and is intended for inhalation. No other information is available as the text is incomplete and not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.